This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M aan het Rot , KA Collins , JW Murrough , AM Perez , . (2010). Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biological Psychiatry 67, 139–145.
I Allaman , H Fiumelli , PJ Magistretti , JL Martin (2011). Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berlin) 216, 75–84.
CA Altar , RE Whitehead , R Chen , G Wortwein , . (2003). Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biological Psychiatry 54, 703–709.
AE Autry , M Adachi , E Nosyreva , ES Na , . (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91–95.
RM Berman , A Cappiello , A Anand , DA Oren , . (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 47, 351–354.
N Diazgranados , L Ibrahim , NE Brutsche , A Newberg , . (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry 67, 793–802.
U Faraguna , VV Vyazovskiy , AB Nelson , G Tononi , . (2008). A causal role for brain-derived neurotrophic factor in the homeostatic regulation of sleep. Journal of Neuroscience 28, 4088–4095.
I Feinberg , IG Campbell (1993). Ketamine administration during waking increases delta EEG intensity in rat sleep. Neuropsychopharmacology 9, 41–48.
Y Gorgulu , O Caliyurt (2009). Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Research Bulletin 80, 158–162.
UM Hemmeter , J Hemmeter-Spernal , JC Krieg (2010). Sleep deprivation in depression. Expert Reviews of Neurotherapeutics 10, 1101–1115.
JR Hughes (1996). A review of the usefulness of the standard EEG in psychiatry. Clinical Electroencephalography 27, 35–39.
SS Husain , IM Kevan , R Linnell , AI Scott (2004). Electroconvulsive therapy in depressive illness that has not responded to drug treatment. Journal of Affective Disorders 83, 121–126.
L Ibrahim , N DiazGranados , J Franco-Chaves , N Brutsche , . (2012). Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs. add-on riluzole: results from a four-week, double-blind, placebo-controlled study. Neuropsychopharmacology 37, 1526–1533.
LC Johnson , K Hanson , RG Bickford (1976). Effect of flurazepam on sleep spindles and K-complexes. Electroencephalography and Clinical Neurophysiology 40, 67–77.
F Karege , G Perret , G Bondolfi , M Schwald , . (2002 a). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 109, 143–148.
F Karege , M Schwald , M Cisse (2002 b). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters 328, 262–264.
V Knott , J McIntosh , A Millar , D Fisher , . (2006). Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist. Pharmacology, Biochemistry, and Behavior 85, 228–242.
V Knott , A Millar , J McIntosh , DK Shah , . (2011). Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention. Biological Psychiatry 88, 83–93.
AH Kossel , SB Cambridge , U Wagner , T Bonhoeffer (2001). A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation. Proceedings of the National Academy of Sciences USA 98, 14702–14707.
N Li , B Lee , RJ Liu , M Banasr , . (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959–964.
B Lu (2003). BDNF and activity-dependent synaptic modulation. Learning and Memory 10, 86–98.
R Machado-Viera , P Yuan , N Brutsche , N DiazGranados , . (2009). Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. Journal of Clinical Psychiatry 70, 1662–1666.
S Maeng , CA Zarate Jr. ( 2007). The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Current Psychiatry Reports 9, 467–474.
E Messaoudi , T Kanhema , J Soule , A Tiron , . (2007). Sustained Arc/Arc3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization of the dentate gyrus in vivo. Journal of Neuroscience 27, 10445–10455.
SA Montgomery , M Asberg (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382–389.
W Pan , WA Banks , MB Fasold , J Bluth , . (1998). Transport of brain derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37, 1553–1561.
C Pittenger , V Coric , M Banasr , M Bloch , . (2008). Riluzole in the treatment of mood and anxiety disorders. CNS Drugs 22, 761–786.
SH Preskorn , B Baker , S Kolluri , FS Menniti , . (2008). An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. Journal of Clinical Psychopharmacology 28, 631–637.
GZ Reus , RB Stringari , KF Ribeiro , AK Ferraro , . (2011). Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behavioural Brain Research 221, 166–171.
RJ Schloesser , LD Huang , PS Klein , HK Manji (2008). Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacolgy 33, 110–113.
S Sen , R Duman , G Sanacora (2008). Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 64, 527–532.
GW Valentine , GF Mason , R Gomez , M Fasula , . (2011). The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Research 191, 122–127.
VV Vyazovskiy , C Cirelli , M Pfister-Genskow , U Faraguna , . (2008). Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nature Neuroscience 11, 200–208.
CA Zarate Jr., JL Payne , J Quiroz , J Sporn , . ( 2004). An open-label trial of riluzole in patients with treatment-resistant major depression. American Journal of Psychiatry 161, 171–174.
CA Zarate Jr., JB Singh , PJ Carlson , NE Brutsche , . ( 2006 a). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63, 856–864.
CA Zarate Jr., JB Singh , JA Quiroz , G De Jesus , . ( 2006 b). A double-blind, placebo-controlled study of memantine in the treatment of major depression. American Journal of Psychiatry 163, 153–155.